rxstat › Shortages › Pantoprazole

Pantoprazole shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Pantoprazole products are in shortage in Canada (7 of 35 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 29, 2026.
Products affected
7 / 35
In shortage since
Jan 1, 2020
Est. full return
Sep 29, 2026
Reports on file
137
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
PANTOPRAZOLE T
40MG · TABLET (DELAYED-RELEASE) · SANIS HEALTH INC
DIN 02466147 · since Apr 29, 2026, est. end Sep 11, 2026 · Disruption of the manufacture of the drug.
Active shortage
MYLAN-PANTOPRAZOLE T
40MG · TABLET (DELAYED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02408570 · since Dec 22, 2025, est. end Sep 29, 2026 · Demand increase for the drug.
Active shortage
TEVA-PANTOPRAZOLE MAGNESIUM
40MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02440628 · since Sep 17, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
PANTOPRAZOLE T
40MG · TABLET (DELAYED-RELEASE) · SANIS HEALTH INC
DIN 02466147 · since Dec 8, 2025, no end estimate · Other (Please describe in comments)
Active shortage
PANTOPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · SANIS HEALTH INC
DIN 02370808 · since Nov 11, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-PANTOPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02285479 · since Mar 6, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-PANTOPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · TEVA CANADA LIMITED
DIN 02285487 · since Nov 8, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
JAMP-PANTOPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02408414 · since Jan 1, 2020, est. end Sep 30, 2021 · Disruption of the manufacture of the drug.
Anticipated
PANTOPRAZOLE MAGNESIUM
40MG · TABLET (DELAYED-RELEASE) · SIVEM PHARMACEUTICALS ULC
DIN 02519534 · Disruption of the manufacture of the drug.
Resolved
SANDOZ PANTOPRAZOLE
20MG · TABLET (DELAYED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02301075 · ended Jun 29, 2026 · Disruption of the manufacture of the drug.
Resolved
TECTA
40MG · TABLET (ENTERIC-COATED) · TAKEDA CANADA INC
DIN 02267233 · ended Jun 12, 2026 · Demand increase for the drug.
Resolved
SPC-PANTOPRAZOLE
40MG · TABLET (DELAYED-RELEASE) · SUN PHARMA CANADA INC
DIN 02305046 · ended Mar 24, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Pantoprazole is currently affected by 7 active shortage reports filed with Health Canada by SANIS HEALTH INC, MYLAN PHARMACEUTICALS ULC, TEVA CANADA LIMITED, JAMP PHARMA CORPORATION.

The reported causes are: disruption of the manufacture of the drug; demand increase for the drug; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Pantoprazole is classified under “DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)” (ATC A02BC).

Recent changes

Common questions

When will Pantoprazole be back in stock in Canada?

The latest manufacturer estimate is Sep 29, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Pantoprazole in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs for peptic ulcer and gastroesophageal reflux disease (gerd))

Widespread shortageFamotidine3 of 13 reported products affected · est. return Sep 18, 2026Partial shortageCimetidine3 of 9 reported products affectedPartial shortageEsomeprazole12 of 26 reported products affected · est. return Oct 10, 2027Partial shortageLansoprazole6 of 22 reported products affected · est. return Dec 29, 2026Partial shortageOmeprazole10 of 22 reported products affected · est. return Aug 14, 2026Partial shortageRabeprazole4 of 21 reported products affected · est. return Jun 30, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.